Brief: Gracell Biotechnologies Inc Files For Resale Of Up To 183.7 Million Ordinary Shares By The Selling Shareholders - SEC Filing
24/08/2023 21:45
Gracell Biotechnologies Inc GRCL.O :
* GRACELL BIOTECHNOLOGIES INC FILES FOR RESALE OF UP TO
183.7
MILLION ORDINARY SHARES BY THE SELLING SHAREHOLDERS - SEC FILING
Source text for Eikon: ID:
Further company coverage: GRCL.O
Recent news on Gracell Biotechnologies
See all newsBrief: Gracell Biotechnologies Announces Shareholders’ Approval Of Merger Agreement
Brief: Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
Newscasts - UK Day Ahead: European shares start last week of 2023 on strong footing
Live Markets: European futures rise after holiday break
Press Digest: British Business - Dec 27